Search clinical trials for: gammaCore®-R

Total 15452 results

ElectroCore INC

Completed

A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine

Migraine

Belgium, Denmark, Germany, Greece, Netherlands, Norway, Spain, United Kingdom
Carlos Tornero

Completed

Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIOR)

Covid-19

Spain
ElectroCore INC

Completed

Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache (CH)

Cluster Headache

United States
Turkish Stroke Research and Clinical Trials Network
ElectroCore INC; Turkish Neurological Society

Completed

Non-invasive TRanscutaneous Cervical Vagus Nerve Stimulation as a Treatment for Acute Stroke; Safety and Feasibility Study (TR-VENUS)

Stroke | Stroke, Ischemic | Stroke, Acute | Stroke, Hemorrhagic

Turkey
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Families Together: Intervention for Reunified Families

Child Abuse | Child Neglect

United States
University of Texas Southwestern Medical Center
ElectroCore INC

Withdrawn

Study of Gammacore Sapphire for the Acute and Preventive Treatment of Post-Traumatic Headache (GAP-PTH)

Post-Traumatic Headache

United States
CentraCare
ElectroCore INC

Completed

Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury

Traumatic Brain Injury | Acute Brain Injuries

United States
ElectroCore INC

Completed

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Chronic Migraine

United States
Allegheny Singer Research Institute (also known...
ElectroCore INC

Terminated

Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)

Respiratory Failure | COVID | Corona Virus Infection | Respiratory Distress Syndrome, Adult | SARS (Severe Acute Respiratory Syndrome) | ARDS, Human

United States
ElectroCore INC

Completed

Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines

Migraine Disorders

United States
Massachusetts General Hospital
ElectroCore INC

Recruiting

Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage (STORM)

Subarachnoid Hemorrhage, Aneurysmal

United States
Northwell Health

Completed

Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage (VANQUISH)

Subarachnoid Hemorrhage, Aneurysmal

United States
ElectroCore INC

Completed

Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care

Chronic Cluster Headache

Belgium, Germany, Italy, United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

Infertility

Canada
ElectroCore INC

Completed

A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G

Dyspepsia | Irritable Bowel Syndrome

United Kingdom
ElectroCore INC

Completed

RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks

Migraine

Italy
ElectroCore INC

Terminated

Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy

Seizure

Australia
ElectroCore INC

Completed

A Randomized Multicentre Study for the Acute Relief of Episodic and Chronic Cluster Headache.

Cluster Headache

Denmark, Germany, Netherlands, United Kingdom
ElectroCore INC

Terminated

Non-invasive Neurostimulation for the Relief of Migraine

Migraine
Assistance Publique - Hôpitaux de Paris

Completed

Correction by ECCO2-R of Hypercapnia in Patients With DVP in Moderate to Severe ARDS Under Protective Ventilation. (COVAP)

Acute Respiratory Distress Syndrome | Hypercapnia

France
GlaxoSmithKline

Completed

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

Hepatitis A

United States
University of Alabama at Birmingham

Active, not recruiting

Vagal Nerve Stimulation for Treatment Resistant Major Depression

Major Depressive Disorder

United States
Johns Hopkins University
ElectroCore INC

Completed

Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders (nVNS)

Gastroparesis | Chronic Unexplained Nausea and Vomiting

United States
Merck KGaA, Darmstadt, Germany

Completed

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

Turner's Syndrome

France
Merck KGaA, Darmstadt, Germany

Completed

A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood

Growth Hormone Deficiency | Dwarfism
Wockhardt

Terminated

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Type I Diabetes

United States, India
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) (ESPART)

Infertility

Germany
ElectroCore INC

Completed

Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine

Migraine

United States
New York State Institute for Basic Research
Boston Children's Hospital; Rutgers University

Recruiting

Vagus Nerve Stimulator for Autism and Other Developmental Disorders (VNS)

Intellectual Disability | Autism Spectrum Disorder | Developmental Disability | Autonomic Nervous System

United States
Merck KGaA, Darmstadt, Germany

Completed

A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

Idiopathic Short Stature

Korea, Republic of
Biocon Limited
Profil Institut für Stoffwechselforschung GmbH

Completed

Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

Healthy Volunteer

Germany
University of Toledo Health Science Campus
ElectroCore INC

Terminated

Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.

Raynaud Disease | Raynaud Phenomenon | Primary Raynaud Phenomenon | Raynaud Syndrome

United States
Aalborg University Hospital
ElectroCore INC

Completed

Treatment of Complications to Diabetic Autonomic Neuropathy With Vagus Nerve Stimulation (DAN-VNS)

Diabetes Mellitus | Gastrointestinal Dysfunction

Denmark
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Varicella

United States
pfm S.R.L.

Completed

Safety and Effectiveness of the Device "Nit-Occlud® PDA-R"

Congenital Heart Disease

Bolivia
Merck KGaA, Darmstadt, Germany
Merck Serono S.A., Geneva

Completed

Saizen in Intra-uterine Growth Retardation

Children Born With Serious Intra-uterine Growth Retardation
Rigshospitalet, Denmark
Aarhus University Hospital; Octapharma Pharmazeutika Produktionsges.m.b.H.

Completed

Immunoglobulin Dosage and Administration Form in CIDP and MMN

Chronic Inflammatory Demyelinating Polyneuropathy | Hemolytic Anemia | Multifocal Motor Neuropathy

Denmark
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Terminated

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

Infertility | Ovulation Induction

Spain
Indiana University
ElectroCore INC

Recruiting

Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study (VNS)

Crohn Disease

United States
EMD Serono

Terminated

Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

Growth Hormone Deficiency (GHD)

United States
Rigshospitalet, Denmark
Aalborg University Hospital

Not yet recruiting

Vagus Nerve Stimulation for Systemic Lupus Erythematous (SLE-VNS)

Fatigue | Systemic Lupus Erythematosus | Autonomic Dysfunction | Autonomic Neuropathy
University of Maryland, Baltimore
Vapotherm, Inc.

Completed

Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)

Healthy Adult Volunteers

United States
GlaxoSmithKline
Parexel

Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Measles | Rubella | Mumps

United States, Slovakia, Estonia
Emory University
Georgia Institute of Technology

Completed

Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder

PostTraumatic Stress Disorder

United States
Merck KGaA, Darmstadt, Germany

Completed

Lutropin Alfa in Women at Risk of Poor Response

Ovarian Stimulation

Spain
Wake Forest University Health Sciences

Active, not recruiting

SNIFF Multi-Device Study 2

Cognitive Impairment | Mild Cognitive Impairment

United States
University of California, Los Angeles
University of Colorado, Denver; National Institute of Allergy and Infectious... and other collaborators

Completed

Centralized Reminder Recall - Flu RCT2

RNA Virus Infections | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Respiratory Tract Disease | Virus Disease | Physiological Effects of Drugs | Vaccines

United States
Nabi Biopharmaceuticals

Completed

Antibody and Safety Study of 6 Doses of NicVAX in Smokers

Smoking

United States
Sanofi

Withdrawn

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

Type 1 Diabetes Mellitus
Klinikum Nürnberg

Unknown

RV Septal Versus Minimized RV Pacing in Sick Sinus Syndrome (VOTE)

Sick Sinus Syndrome

Germany

Search clinical trials for: gammaCore®-R

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations